Home » Topics » Science » New compound

New compound
RSS

Anti-CD3 DARPin T-cell engager is active only in the tumor microenvironment

May 11, 2021

GQ-127 shows in vitro and in vivo antitumor activity in uveal melanoma

May 10, 2021

Discovery and preclinical characterization of novel bifunctional anti-PD-1 x IL-15 proteins

May 7, 2021

Intraocular pressure lowering by soluble guanylate cyclase inhibitor ID-65-CW69 studied in monkeys

May 7, 2021

Boswellic acid derivative inhibits Th17 cell differentiation by targeting eIF2alpha

May 6, 2021

Novel GLUT5 inhibitor molecule to treat fructose-induced diseases

May 6, 2021

Preclinical characterization of novel small molecule inhibitor of CD38, RBN-013209

May 5, 2021

Zenshine compounds targeting E-NPP 1 have antitumor activity

May 5, 2021

KRAS G12C inhibitor BI-1823911 shows in vivo efficacy, to enter clinical study

April 28, 2021

Aurigene details preclinical activity of anticancer compounds AU-18069 and AU-19820

April 27, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...